3 Things You Should Know About Frontline and Maintenance Therapy for HER2+ Metastatic Breast Cancer.
| Published in: | Oncology (08909091) Vol. 40; no. 4; pp. 43 - 47 |
|---|---|
| Main Authors: | , , , |
| Format: | CEU exam questions tables/charts Journal Article |
| Published: |
MJH Life Sciences
May2026
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=194762589&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 194762589 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 08909091 YYT jtl: Oncology (08909091) issn: 08909091 maglogo: N pubinfo: dt: May2026 vid: 40 iid: 4 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 194762589 194762589 194762589 194762589 ppf: 43 ppct: 4 formats: fmt: @attributes: type: P tig: atl: 3 Things You Should Know About Frontline and Maintenance Therapy for HER2+ Metastatic Breast Cancer. aug: au: O'Shaughnessy, Joyce Mahtani, Reshma L. McArthur, Heather Tarantino, Paolo affil: Celebrating Women Chair in Breast Cancer Research, Baylor University Medical Center, Director, Breast Cancer Research Program, Texas Oncology, US Oncology, Dallas, TX sug: subj: Breast Neoplasms Drug Therapy Neoplasm Metastasis Drug Therapy Antineoplastic Agents, Combined Therapeutic Use Education, Continuing (Credit) Disease Progression Risk Factors Tyrosine Kinase Inhibitors Treatment Outcomes Risk Assessment pubtype: Academic Journal doctype: CEU exam questions tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|